SEC 13F Intelligence

Taal Capital Management LP / IMMU

Taal Capital Management LP’s Immunomedics Inc Position

Does Taal Capital Management LP own Immunomedics Inc (IMMU)? Not currently — the last reported position was 50.0K shares worth $4M in Q3 2020; the fund’s latest 13F (Q2 2021) no longer reports it.

Position Value
$4M
Q3 2020
Shares
50.0K
% of Portfolio
+4.17%
Quarters Held
1
position exited

Position History IMMU

Reported value by quarter
Q3 ’20: $4MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202050.0K$4M+4.17%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Taal Capital Management LP’s full portfolio or all institutional holders of IMMU.